CLX
48
2
SWK
64
-4
MTB
52
-4
RIG
38
-2
PSX
59
4
DUK
52
-2
SEE
55
7
ROP
41
5
NVDA
71
-2
AME
62
-6
APA
52
2
WU
19
2
ED
34
-3
PCG
72
-5
XYL
64
-2
CI
63
4
NRG
44
-5
HD
58
9
CFG
67
-2
SNA
48
2
CLX
48
2
SWK
64
-4
MTB
52
-4
RIG
38
-2
PSX
59
4
DUK
52
-2
SEE
55
7
ROP
41
5
NVDA
71
-2
AME
62
-6
APA
52
2
WU
19
2
ED
34
-3
PCG
72
-5
XYL
64
-2
CI
63
4
NRG
44
-5
HD
58
9
CFG
67
-2
SNA
48
2
Financhill
Back

Cognizant Technology Solutions Corp. - Ordinary Shares - Class A Vs. Nektar Therapeutics Industry Stock Comparison

Sell
39

CTSH
Cognizant Technology Solutions Corp. - Ordinary Shares - Class A

Last Price:
$70.11
Seasonality Move:
9.46%
Buy
62

NKTR
Nektar Therapeutics

Last Price:
$27.39
Seasonality Move:
6.79%
Sell
39
Cognizant Technology Solutions Corp. - Ordinary Shares - Class A (CTSH) is a Sell

Is Cognizant Technology Solutions Corp. - Ordinary Shares - Class A a Buy, Sell or Hold?

  • The current Cognizant Technology Solutions Corp. - Ordinary Shares - Class A [CTSH] share price is $70.00. The Score for CTSH is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • CTSH is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
62
Nektar Therapeutics (NKTR) is a Buy

Is Nektar Therapeutics a Buy, Sell or Hold?

  • The current Nektar Therapeutics [NKTR] share price is $27.26. The Score for NKTR is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
  • NKTR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

CTSH Stock Price Chart

What is Cognizant Technology Solutions Corp. - Ordinary Shares - Class A's stock price today?

NKTR Stock Price Chart

What is Nektar Therapeutics's stock price today?

  • The Nektar Therapeutics share price today is $27.26
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NKTR is experiencing slight selling pressure.

CTSH Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 16.89 Buy
Relative Strength Index (14 RSI): 38.29 Sell
Chaikin Money Flow: 2037517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (70.02 - 75.84) Sell
Bollinger Bands (100): (71.73 - 80.19) Sell

NKTR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.04 Buy
Relative Strength Index (14 RSI): 66.02 Buy
Chaikin Money Flow: -23288 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (22.49 - 25.51) Buy
Bollinger Bands (100): (8.3 - 22.66) Buy

CTSH Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 69.66 Buy
20-day SMA: 72.37 Sell
50-day SMA: 75.97 Sell
200-day SMA: 78.16 Sell
8-day EMA: 67.78 Buy
20-day EMA: 52.92 Buy
50-day EMA: 30.22 Buy
200-day EMA: 9.22 Buy

NKTR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 24.13 Buy
20-day SMA: 23.8 Buy
50-day SMA: 20.82 Buy
200-day SMA: 15.1 Buy
8-day EMA: 24.9 Buy
20-day EMA: 23.86 Buy
50-day EMA: 21.15 Buy
200-day EMA: 16.63 Buy

Cognizant Technology Solutions Corp. - Ordinary Shares - Class A Earnings Growth & CTSH Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.14 per share, an increase next quarter of $0.14 per share, an increase this year of $0.43 per share, and an increase next year of $0.41 per share.

Nektar Therapeutics Earnings Growth & NKTR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.22 per share, a decrease next quarter of $0.01 per share, an increase this year of $2.16 per share, and a decrease next year of $1.84 per share.

Cognizant Technology Solutions Corp. - Ordinary Shares - Class A Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nektar Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):